Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "poxvirus" refers to members of the Poxviridae family, which comprises large, complex, double-stranded DNA viruses. These viruses are brick-shaped or oval, with a lipoprotein envelope, and replicate exclusively in the cytoplasm of host cells using virus-encoded proteins[1][2][3][5]. The family includes significant human and animal pathogens, such as variola virus (smallpox), monkeypox virus, vaccinia virus, and molluscum contagiosum virus. Poxviruses can evade the immune system, are highly infectious, and can spread via direct contact, respiratory droplets, and environmental surfaces. The term "poxvirus" is not a molecular target but a virus family, so queries about receptor, enzyme, or transporter roles are not directly applicable.
Inhibition of viral DNA replication (cidofovir, brincidofovir), inhibition of viral envelope formation and egress (tecovirimat)[6]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poxvirus (family Poxviridae).